Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) 是一种用于治疗精神疾病的药物。它也是一种医药和建筑材料, 可用于氨基酸定量分析时的梯度洗脱。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
500 mg | ¥ 99 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 150 | 现货 |
产品描述 | Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) , the active component of Lithium, is a medicine used in the therapy of psychiatric disease. It has shown the effects of signaling pathways and metabolic in the brain based on the particular disease and clinical condition model. According to the reports, Citric acid trilithium salt tetrahydrate was used as a mood stabilizer when treating bipolar mood disorders (BD) and lower the risk of self-harm in BD patient. In addition,Citric acid trilithium salt tetrahydrate has been the choice drug in the therapy of acute manic episodes.Citric acid trilithium salt tetrahydrate also could dissolve uric acid crystals in urine achieved from patients with gout. Besides,Citric acid trilithium salt tetrahydrate have some dose-dependent side-effects. The the main side-effects of Lithium Citrate is the tendency to inhibit the prostatic acid phosphatase enzyme (PAP), which result in the accumulation of PAP. |
别名 | Lithium citrate tribasic tetrahydrate, 柠檬酸三锂盐四水合物, Trilithium citrate tetrahydrate |
分子量 | 281.98 |
分子式 | C6H13Li3O11 |
CAS No. | 6080-58-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 52 mg/mL (184.4 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 51 mg/mL (180.9 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / H2O | 1 mM | 3.5464 mL | 17.7318 mL | 35.4635 mL | 88.6588 mL |
5 mM | 0.7093 mL | 3.5464 mL | 7.0927 mL | 17.7318 mL | |
10 mM | 0.3546 mL | 1.7732 mL | 3.5464 mL | 8.8659 mL | |
20 mM | 0.1773 mL | 0.8866 mL | 1.7732 mL | 4.4329 mL | |
50 mM | 0.0709 mL | 0.3546 mL | 0.7093 mL | 1.7732 mL | |
100 mM | 0.0355 mL | 0.1773 mL | 0.3546 mL | 0.8866 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Citric acid trilithium salt tetrahydrate 6080-58-6 Chromatin/Epigenetic Metabolism Microbiology/Virology Neuroscience PI3K/Akt/mTOR signaling Stem Cells Dehydrogenase GSK-3 HIF/HIF Prolyl-Hydroxylase Antibacterial GluR HIF-1α Lithium citrate tribasic tetrahydrate HIF-PH Lithium citrate tribasic Tetrahydrate Citrate CaOx ACLY ATP Citrate Lyase Litarex tetrahydrate Trilithium citrate Tetrahydrate HIFs Lithium citrate tetrahydrate 柠檬酸三锂盐四水合物 cleavage Bacterial Trilithium citrate tetrahydrate Hypoxia-inducible factors Lithium citrate tribasic stones extramitochondrial antioxidation Citric acid trilithium Tetrahydrate Trilithium Citrate inhibit ATP Inhibitor anti-inflammation Citric acid safety inhibitor